![Marc d'Abbadie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marc d'Abbadie
Direttore/Membro del Consiglio presso
Spark Nw Carry Partner LLP
Profilo
Dr. Marc d'Abbadie is an Investment Director at SPARK Impact Ltd. He is on the Board of Directors at Dadu Investments Ltd., Nwf4b Directors Ltd., Spark Nw Carry Partner LLP and Videregen Ltd.
Dr. d'Abbadie was previously employed as a Non-Executive Director by Evgen Pharma Plc, a Non-Executive Director by Evgen Ltd., a Non-Executive Director by Absynth Biologics Ltd., a Non-Executive Director by EnXray Ltd., a Consultant by McKinsey & Co., Inc., and a Non-Executive Director by Zilico Ltd.
He received his graduate degree from Trinity College, Cambridge and a doctorate degree from the University of Cambridge.
Posizioni attive di Marc d'Abbadie
| Società | Posizione | Inizio |
|---|---|---|
SPARK Impact Ltd.
 SPARK Impact Ltd. Investment ManagersFinance SPARK Impact invests in companies located in the United Kingdom. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, diagnostics, clinical research, analytical services & sciences, healthcare technologies and medical devices. It provides financing for early and growth stage capital requirements. | Investitore di Private Equity | - |
Videregen Ltd.
 Videregen Ltd. BiotechnologyHealth Technology Operates a regenerative medicine company created to address the chronic shortage of organs for transplantation | Direttore/Membro del Consiglio | - |
Spark Nw Carry Partner LLP | Direttore/Membro del Consiglio | - |
Nwf4b Directors Ltd. | Direttore/Membro del Consiglio | - |
Dadu Investments Ltd. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Marc d'Abbadie
| Società | Posizione | Fine |
|---|---|---|
| THERACRYF PLC | Direttore/Membro del Consiglio | 08/11/2018 |
EnXray Ltd.
 EnXray Ltd. Information Technology ServicesTechnology Services Develops sterilization technology solutions for medical device manufacturing companies | Direttore/Membro del Consiglio | - |
Absynth Biologics Ltd.
 Absynth Biologics Ltd. BiotechnologyHealth Technology Develops and manufactures immunological prophylaxis, novel vaccines and therapies | Direttore/Membro del Consiglio | - |
Zilico Ltd.
 Zilico Ltd. BiotechnologyHealth Technology Develops a medical device to detect cervical cancer and pre-cancerous cells in the cervix | Direttore/Membro del Consiglio | - |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Marc d'Abbadie
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
10
Relazioni di 1° grado
13
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
Evgen Pharma Plc
 Evgen Pharma Plc Medical/Nursing ServicesHealth Services Engages in the development of pharmaceutical products and focus on cancer & neurological disease | Health Services |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trinity College, Cambridge
 Trinity College, Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Absynth Biologics Ltd.
Absynth Biologics Ltd. BiotechnologyHealth Technology Develops and manufactures immunological prophylaxis, novel vaccines and therapies | Health Technology |
Zilico Ltd.
Zilico Ltd. BiotechnologyHealth Technology Develops a medical device to detect cervical cancer and pre-cancerous cells in the cervix | Health Technology |
Evgen Ltd.
 Evgen Ltd. Medical/Nursing ServicesHealth Services Develops novel glucosinolate based products for the prevention and treatment of human disease | Health Services |
SPARK Impact Ltd.
SPARK Impact Ltd. Investment ManagersFinance SPARK Impact invests in companies located in the United Kingdom. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, diagnostics, clinical research, analytical services & sciences, healthcare technologies and medical devices. It provides financing for early and growth stage capital requirements. | Finance |
Videregen Ltd.
Videregen Ltd. BiotechnologyHealth Technology Operates a regenerative medicine company created to address the chronic shortage of organs for transplantation | Health Technology |
Spark Nw Carry Partner LLP | |
Nwf4b Directors Ltd. | |
Dadu Investments Ltd. | |
EnXray Ltd.
EnXray Ltd. Information Technology ServicesTechnology Services Develops sterilization technology solutions for medical device manufacturing companies | Technology Services |
